262 related articles for article (PubMed ID: 27330931)
21. Pre-treatment allergen-specific IgE analysis and outcomes of allergen immunotherapy.
Berge M; Bertilsson L; Hultgren O; Hugosson S; Saber A
Eur Ann Allergy Clin Immunol; 2022 Sep; 54(5):218-228. PubMed ID: 33939346
[No Abstract] [Full Text] [Related]
22. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.
Larenas-Linnemann D; Rodríguez-Pérez N; Luna-Pech JA; Rodríguez-González M; Blandón-Vijil MV; Del-Río-Navarro BE; Costa-Domínguez MDC; Navarrete-Rodríguez EM; Macouzet-Sánchez C; Ortega-Martell JA; Pozo-Beltrán CF; Estrada-Cardona A; Arias-Cruz A; Rodríguez Galván KG; Brito-Díaz H; Canseco-Raymundo MDR; Castelán-Chávez EE; Escalante-Domínguez AJ; Gálvez-Romero JL; Gómez-Vera J; González-Díaz SN; Guerrero-Núñez MGB; Hernández-Colín DD; Macías-Weinmann A; Mendoza-Hernández DA; Meneses-Sánchez NA; Mogica-Martínez MD; Moncayo-Coello CV; Montiel-Herrera JM; O'Farril-Romanillos PM; Onuma-Takane E; Ortega-Cisneros M; Rangel-Garza L; Stone-Aguilar H; Torres-Lozano C; Venegas-Montoya E; Wakida-Kusunoki G; Partida-Gaytán A; López-García AI; Macías-Robles AP; Ambriz-Moreno MJ; Azamar-Jácome AA; Beltrán-De Paz CY; Caballero-López C; Fernández de Córdova-Aguirre JC; Fernández-Soto JR; Lozano-Sáenz JS; Oyoqui-Flores JJ; Osorio-Escamilla RE; Ramírez-Jiménez F; Rivero-Yeverino D; Martínez Infante E; Medina-Ávalos MA
World Allergy Organ J; 2020 Aug; 13(8):100444. PubMed ID: 32884611
[TBL] [Abstract][Full Text] [Related]
23. Past, present, and future of allergen immunotherapy vaccines.
Dorofeeva Y; Shilovskiy I; Tulaeva I; Focke-Tejkl M; Flicker S; Kudlay D; Khaitov M; Karsonova A; Riabova K; Karaulov A; Khanferyan R; Pickl WF; Wekerle T; Valenta R
Allergy; 2021 Jan; 76(1):131-149. PubMed ID: 32249442
[TBL] [Abstract][Full Text] [Related]
24. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
[TBL] [Abstract][Full Text] [Related]
25. Changes in Immunologic Indicators During Allergen-Specific Immunotherapy for Allergic Rhinitis and Determinants of Variability: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Jiang Z; Xiao H; Liu S; Meng J
Am J Rhinol Allergy; 2021 Nov; 35(6):910-922. PubMed ID: 33631946
[TBL] [Abstract][Full Text] [Related]
26. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy.
Pajno GB; Fernandez-Rivas M; Arasi S; Roberts G; Akdis CA; Alvaro-Lozano M; Beyer K; Bindslev-Jensen C; Burks W; Ebisawa M; Eigenmann P; Knol E; Nadeau KC; Poulsen LK; van Ree R; Santos AF; du Toit G; Dhami S; Nurmatov U; Boloh Y; Makela M; O'Mahony L; Papadopoulos N; Sackesen C; Agache I; Angier E; Halken S; Jutel M; Lau S; Pfaar O; Ryan D; Sturm G; Varga EM; van Wijk RG; Sheikh A; Muraro A;
Allergy; 2018 Apr; 73(4):799-815. PubMed ID: 29205393
[TBL] [Abstract][Full Text] [Related]
27. IL-4 receptor α blockade prevents sensitization and alters acute and long-lasting effects of allergen-specific immunotherapy of murine allergic asthma.
Russkamp D; Aguilar-Pimentel A; Alessandrini F; Gailus-Durner V; Fuchs H; Ohnmacht C; Chaker A; de Angelis MH; Ollert M; Schmidt-Weber CB; Blank S
Allergy; 2019 Aug; 74(8):1549-1560. PubMed ID: 30829405
[TBL] [Abstract][Full Text] [Related]
28. [Allergen immunotherapy - a position paper of the German society for allergology and clinical immunology].
Kleine-Tebbe J; Fuchs T; Klimek L; Kühr J; Lepp U; Niggemann B; Rakoski J; Renz H; Saloga J; Simon J
Pneumologie; 2001 Sep; 55(9):438-44. PubMed ID: 11536068
[TBL] [Abstract][Full Text] [Related]
29. Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
Tulaeva I; Kratzer B; Campana R; Curin M; van Hage M; Karsonova A; Riabova K; Karaulov A; Khaitov M; Pickl WF; Valenta R
Front Immunol; 2020; 11():1368. PubMed ID: 32733455
[TBL] [Abstract][Full Text] [Related]
30. Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy.
Bordas-Le Floch V; Berjont N; Batard T; Varese N; O'Hehir RE; Canonica WG; van Zelm MC; Mascarell L
Allergy; 2022 Apr; 77(4):1263-1273. PubMed ID: 34551124
[TBL] [Abstract][Full Text] [Related]
31. Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG
Eckl-Dorna J; Weber M; Stanek V; Linhart B; Ristl R; Waltl EE; Villazala-Merino S; Hummel A; Focke-Tejkl M; Froeschel R; Neubauer A; Henning R; Perkmann T; Valenta R; Niederberger V
EBioMedicine; 2019 Dec; 50():421-432. PubMed ID: 31786130
[TBL] [Abstract][Full Text] [Related]
32. @IT2020: An innovative algorithm for allergen immunotherapy prescription in seasonal allergic rhinitis.
Arasi S; Castelli S; Di Fraia M; Villalta D; Tripodi S; Perna S; Dramburg S; Brighetti MA; Conte M; Martelli P; Sfika I; Travaglini A; Verardo PL; Villella V; Matricardi PM
Clin Exp Allergy; 2021 Jun; 51(6):821-828. PubMed ID: 33759270
[TBL] [Abstract][Full Text] [Related]
33. Recombinant allergens for immunotherapy: state of the art.
Zhernov Y; Curin M; Khaitov M; Karaulov A; Valenta R
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):402-414. PubMed ID: 31082821
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
35. The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy.
Ciprandi G; Tosca MA; Silvestri M
Expert Rev Clin Immunol; 2014 Mar; 10(3):321-4. PubMed ID: 24450987
[TBL] [Abstract][Full Text] [Related]
36. Use of biologics in allergen immunotherapy.
Pfützner W; Schuppe M
Allergol Select; 2021; 5():108-118. PubMed ID: 33634221
[TBL] [Abstract][Full Text] [Related]
37. Greater Real-Life Diagnostic Efficacy of Allergen Molecule-Based Diagnosis for Prescription of Immunotherapy in an Area with Multiple Pollen Exposure.
Saltabayeva U; Garib V; Morenko M; Rosenson R; Ispayeva Z; Gatauova M; Zulus L; Karaulov A; Gastager F; Valenta R
Int Arch Allergy Immunol; 2017; 173(2):93-98. PubMed ID: 28654920
[TBL] [Abstract][Full Text] [Related]
38. Allergen-specific Immunotherapy for Inhalant Allergens in Children.
Caffarelli C; Cangemi J; Mastrorilli C; Giannetti A; Ricci G
Curr Pediatr Rev; 2020; 16(2):129-139. PubMed ID: 31642784
[TBL] [Abstract][Full Text] [Related]
39. Allergen immunotherapy for respiratory allergies in clinical practice: A comprehensive review.
Lao-Araya M; Sompornrattanaphan M; Kanjanawasee D; Tantilipikorn P;
Asian Pac J Allergy Immunol; 2022 Dec; 40(4):283-294. PubMed ID: 36681655
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.
Shamji MH; Kappen JH; Akdis M; Jensen-Jarolim E; Knol EF; Kleine-Tebbe J; Bohle B; Chaker AM; Till SJ; Valenta R; Poulsen LK; Calderon MA; Demoly P; Pfaar O; Jacobsen L; Durham SR; Schmidt-Weber CB
Allergy; 2017 Aug; 72(8):1156-1173. PubMed ID: 28152201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
